We are live on
!
Find out more
NSEDCP
NJ State Employees Deferred Compensation Plan Portfolio holdings
AUM
$906M
1-Year Est. Return
24.85%
This Fund
S&P 500
This Quarter
Est. Return
+12.12%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$790M
AUM Growth
+$62.8M
(+8.6%)
Cap. Flow
-$4.7M
Cap. Flow
% of AUM
-0.59%
Top 10 Holdings %
Top 10 Hldgs %
28.54%
Holding
490
New
6
Increased
–
Reduced
3
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTM
Arcadium Lithium plc
ALTM
|
+$555K |
| 2 |
Viking Therapeutics
VKTX
|
+$387K |
| 3 |
KAMN
Kaman Corp
KAMN
|
+$246K |
| 4 |
Radian Group
RDN
|
+$206K |
| 5 |
Selective Insurance
SIGI
|
+$206K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$1.74M |
| 2 |
Microsoft
MSFT
|
+$1.21M |
| 3 |
LTHM
Livent Corporation
LTHM
|
+$827K |
| 4 |
PGTI
PGT, Inc.
PGTI
|
+$814K |
| 5 |
Eli Lilly
LLY
|
+$783K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.38% |
| 2 | Healthcare | 13.34% |
| 3 | Financials | 12% |
| 4 | Industrials | 11.51% |
| 5 | Consumer Discretionary | 9.6% |
Similar funds
IAM
BFS
MSAM
SAM
CP
EAM
HWM
BVDMP
NJ State Employees Deferred Compensation Plan's Q1 2024 Portfolio in Review
As of Q1 2024, NJ State Employees Deferred Compensation Plan held 490 positions worth $790M, up 8.6% from $727M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.1%. NJ State Employees Deferred Compensation Plan opened 6 new positions and exited 9, leaving the 490-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- NJ State Employees Deferred Compensation Plan's largest Q1 2024 buy was Arcadium Lithium plc: 110,676 shares worth $477K.
- NJ State Employees Deferred Compensation Plan's biggest Q1 2024 reduction was Microsoft, cutting an estimated $1.21M.
- NJ State Employees Deferred Compensation Plan fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $1.74M.
- NJ State Employees Deferred Compensation Plan's ten largest holdings make up 29% of its $790M portfolio in Q1 2024.
- NJ State Employees Deferred Compensation Plan opened 6 new positions and closed 9 in Q1 2024.
- NJ State Employees Deferred Compensation Plan's portfolio value rose 8.6% quarter-over-quarter to $790M.
Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q1 2024, filed 2 May 2024.